Bristol-Myers Squibb Company

做多

BMY breakout

由schmidtke_jake提供

strength in drug names, up 20% after EPS another one that gap up on EPS. Looking for to top out at the 63 level a short term 5% move. Hope for the best prepare for the worst.

更多:

相关出版物

NKTR going into earnings

由schmidtke_jake提供

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。